-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
WCLC News
-
WCLC Chairs Welcome Opportunity to Gather Face-to-Face
Challenges remain throughout the world, but the 2022 World Conference on Lung Cancer chairs say the extra effort required to find solutions is worth it.
-
Journal of Thoracic Oncology Impact Factor Surpasses 20
A journal’s impact factor reflects the yearly number of citations of its recently published articles. JTO’s impact factor has consistently grown for the past several years.
-
Step It Up For Research!
Join IASLC’s first annual steps challenge and raise money for cancer research while staying active during WCLC 2022.
-
Foundation Announces 2022 Young Investigator Grant Recipients
The International Lung Cancer Foundation recently awarded $350,000 in grants to support lung cancer research and young investigators.
-
Workshops Offer Opportunities for Education, Networking Based on Shared Interests, Specialties
WCLC 2022 will kick-off with several sessions designed to give specialty audiences more interaction with experts and thought leaders.
-
In Brief for June 22, 2022
See the latest IASLC meeting news, including an extended deadline for ACLC abstract submissions and COVID-19 guideline updates for those traveling to WCLC.
-
Acute Admissions Rates for Lung Cancer Patients Up During Pandemic, Not Linked to COVID-19
Data from a single-center study in Scotland suggested that there were more patients with lung cancer admitted acutely with cancer, non-COVID-19-related illness during the COVID-19 pandemic. “Early and late lockdown were characterized by a reduction in self-presentation and longer resulting admission suggesting that patients were admitted with more complex pathology and consequently had longer admission,”…
-
Modeling Analyses Show That Expansions in Lung Cancer Screening Guidelines to Better Capture Underrepresented Populations Still Need Work
Two abstracts presented at the 2020 World Conference on Lung Cancer shed light on how changes in current screening guidelines can influence lung cancer detection rates, specifically among underrepresented populations. As both studies illustrate, sometimes seemingly innocuous changes intended to improve detection rates can actually have negative consequences. Performance of the Draft 2020 USPSTF Lung…
-
Young Investigators Awarded Grants to Study COVID-19 and Lung Cancer
Lung Ambition Alliance to award four new Junior Faculty Research Grants. Four early-career researchers have been selected to receive the Lung Ambition Alliance Junior Faculty Grants for the Study of COVID-19 and Lung Cancer. Research shows that patients with lung cancer have worse outcomes with COVID-19 and these grants are intended to fund groundbreaking research…
-
Lung Ambition Alliance: Stronger Together
The IASLC has formed an alliance with the Global Lung Cancer Coalition (GLCC), Guardant Health, and AstraZeneca to accelerate the pace of lung cancer survival worldwide. This collaborative effort—known as the Lung Ambition Alliance—allows scientists, specialists, advocates, and patients to break the barriers limiting progress with a goal to double 5-year survival rates of lung…
View ILCN Archives
Provider Resources
Popular Articles